About PT-141
PT-141 (Bremelanotide) is a synthetic peptide studied as a melanocortin receptor agonist in neuroscience and receptor pharmacology research. Supplied as a lyophilized powder for laboratory investigations into melanocortin signaling pathways and CNS-associated signaling mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer.
Recent research on PT-141: Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer.
Read Full Study on PubMedPractical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies.
Recent research on PT-141: Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies.
Read Full Study on PubMedAdditional Studies
Polymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases.
Recent research on PT-141: Polymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases.
Read on PubMedA biodegradable suction patch for sustainable transbuccal peptide delivery.
Recent research on PT-141: A biodegradable suction patch for sustainable transbuccal peptide delivery.
Read on PubMedFemale Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Recent research on PT-141: Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Read on PubMed2024 SOGC, 2024 NCCN, 2022 ESO-ESMO, and 2018 ASCO: a comparison of female cancer survivorship guidelines for the management of sexual health concerns.
Recent research on PT-141: 2024 SOGC, 2024 NCCN, 2022 ESO-ESMO, and 2018 ASCO: a comparison of female cancer survivorship guidelines for the management of sexual health concerns.
Read on PubMedIntravenous peptides and amino acids for erectile dysfunction: a narrative review of current applications and future directions.
Recent research on PT-141: Intravenous peptides and amino acids for erectile dysfunction: a narrative review of current applications and future directions.
Read on PubMedFDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.
Recent research on PT-141: FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.
Read on PubMedRelated Research
Purchase PT-141 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.